دورية أكاديمية
Cigarette and Alternative Tobacco Product Use among Adult Cancer Survivors Enrolled in 9 ECOG-ACRIN Clinical Trials.
| العنوان: | Cigarette and Alternative Tobacco Product Use among Adult Cancer Survivors Enrolled in 9 ECOG-ACRIN Clinical Trials. |
|---|---|
| المؤلفون: | Streck JM; Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts., Lee JW; Dana-Farber Cancer Institute/ECOG-ACRIN Biostatistics Center, Boston, Massachusetts., Walter AW; University of Massachusetts Lowell, Lowell, Massachusetts., Rosen RL; Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts., Gareen IF; Brown University, Providence, Rhode Island., Kircher SM; Northwestern University, Evanston, Illinois., Herman BA; Brown University, Providence, Rhode Island., Carlos RC; University of Michigan, Ann Arbor, Michigan., Kumar S; Mayo Clinic, Rochester, Minnesota., Mayer IA; Vanderbilt University, Nashville, Tennessee., Saba NF; Emory University, Atlanta, Georgia., Fenske TS; Medical College of Wisconsin, Milwaukee, Wisconsin., Neal JW; Stanford University, Stanford, California., Atkins MB; Georgetown University Hospital, Washington, DC., Hodi FS; Dana-Farber Cancer Institute/ECOG-ACRIN Biostatistics Center, Boston, Massachusetts., Kyriakopoulos CE; University of Wisconsin-Madison, Madison, Wisconsin., Tempany C; Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts., Shanafelt TD; Stanford University, Stanford, California., Wagner LI; Wake Forest University, Winston-Salem, North Carolina., Land SR; National Cancer Institute, Rockville, Maryland., Park ER; Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts., Ostroff JS; Memorial Sloan Kettering Cancer Center, New York, New York. |
| المصدر: | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2023 Nov 01; Vol. 32 (11), pp. 1552-1557. |
| نوع المنشور: | Journal Article; Research Support, N.I.H., Extramural |
| اللغة: | English |
| بيانات الدورية: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9200608 Publication Model: Print Cited Medium: Internet ISSN: 1538-7755 (Electronic) Linking ISSN: 10559965 NLM ISO Abbreviation: Cancer Epidemiol Biomarkers Prev Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Philadelphia, PA : American Association for Cancer Research, c1991- |
| مواضيع طبية MeSH: | Cancer Survivors* , Electronic Nicotine Delivery Systems* , Neoplasms*/epidemiology , Tobacco Products* , Tobacco, Smokeless*, Adult ; Female ; Humans ; Male ; Middle Aged ; Adenosine Triphosphate ; Azathioprine ; Tobacco Use/epidemiology ; United States/epidemiology ; Clinical Trials as Topic |
| مستخلص: | Background: While cigarette smoking has declined among the U.S. general population, sale and use of non-cigarette alternative tobacco products (ATP; e.g., e-cigarettes, cigars) and dual use of cigarettes/ATPs are rising. Little is known about ATP use patterns in cancer survivors enrolled in clinical trials. We investigated prevalence of tobacco product use, and factors associated with past 30-day use, among patients with cancer in national trials. Methods: Cancer survivors (N = 756) enrolled in 9 ECOG-ACRIN clinical trials (2017-2021) completed a modified Cancer Patient Tobacco Use Questionnaire (C-TUQ) which assessed baseline cigarette and ATP use since cancer diagnosis and in the past 30 days. Results: Patients were on average 59 years old, 70% male, and the mean time since cancer diagnosis was 26 months. Since diagnosis, cigarettes (21%) were the most common tobacco product used, followed by smokeless tobacco use (5%), cigars (4%), and e-cigarettes (2%). In the past 30 days, 12% of patients reported smoking cigarettes, 4% cigars, 4% using smokeless tobacco, and 2% e-cigarettes. Since cancer diagnosis, 5.5% of the sample reported multiple tobacco product use, and 3.0% reported multiple product use in the past 30 days. Males (vs. females; OR 4.33; P = 0 < 0.01) and individuals not living with another person who smokes (vs. living with; OR, 8.07; P = 0 < 0.01) were more likely to use ATPs only versus cigarettes only in the past 30 days. Conclusions: Among patients with cancer, cigarettes were the most prevalent tobacco product reported. Impact: Regardless, ATPs and multiple tobacco product use should be routinely assessed in cancer care settings. (©2023 American Association for Cancer Research.) |
| References: | JAMA Intern Med. 2020 Oct 1;180(10):1394-1398. (PMID: 32897288) Cancer Med. 2018 Jul;7(7):3484-3491. (PMID: 29905013) J Health Soc Behav. 2000 Mar;41(1):50-67. (PMID: 10750322) MMWR Morb Mortal Wkly Rep. 2019 Nov 15;68(45):1013-1019. (PMID: 31725711) Public Health Rep. 2006 Mar-Apr;121(2):116-9. (PMID: 16528942) BMC Psychiatry. 2010 Sep 30;10:77. (PMID: 20920287) Med Care. 2007 May;45(5 Suppl 1):S3-S11. (PMID: 17443116) Support Care Cancer. 2022 Sep;30(9):7801-7809. (PMID: 35552828) Prev Med. 2020 Nov;140:106099. (PMID: 32335031) MMWR Morb Mortal Wkly Rep. 2020 Nov 20;69(46):1736-1742. (PMID: 33211681) Cancer Epidemiol Biomarkers Prev. 2019 Dec;28(12):2087-2094. (PMID: 31501150) Clin Cancer Res. 2022 Nov 14;28(22):4861-4870. (PMID: 36287033) Psychooncology. 2022 May;31(5):753-760. (PMID: 34797953) Cochrane Database Syst Rev. 2020 Oct 14;10:CD010216. (PMID: 33052602) Stigma Health. 2018 Aug;3(3):195-203. (PMID: 30393760) N Engl J Med. 2018 Jun 28;378(26):2456-2458. (PMID: 29949490) JAMA Intern Med. 2018 Apr 1;178(4):469-476. (PMID: 29459935) JAMA Intern Med. 2015 Sep;175(9):1574-6. (PMID: 26076120) |
| معلومات مُعتمدة: | UG1 CA233277 United States CA NCI NIH HHS; P30 CA008748 United States CA NCI NIH HHS; UG1 CA189828 United States CA NCI NIH HHS; UG1 CA233180 United States CA NCI NIH HHS; UG1 CA233198 United States CA NCI NIH HHS; U10 CA180820 United States CA NCI NIH HHS; UG1 CA239758 United States CA NCI NIH HHS; UG1 CA233290 United States CA NCI NIH HHS; UG1 CA233270 United States CA NCI NIH HHS; UG1 CA233320 United States CA NCI NIH HHS; K23 DA056583 United States DA NIDA NIH HHS; UG1 CA233160 United States CA NCI NIH HHS; UG1 CA232760 United States CA NCI NIH HHS; UG1 CA233247 United States CA NCI NIH HHS; U10 CA180794 United States CA NCI NIH HHS |
| المشرفين على المادة: | 8L70Q75FXE (Adenosine Triphosphate) MRK240IY2L (Azathioprine) |
| تواريخ الأحداث: | Date Created: 20230706 Date Completed: 20231107 Latest Revision: 20240502 |
| رمز التحديث: | 20240502 |
| مُعرف محوري في PubMed: | PMC10773003 |
| DOI: | 10.1158/1055-9965.EPI-23-0420 |
| PMID: | 37410096 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1538-7755 |
|---|---|
| DOI: | 10.1158/1055-9965.EPI-23-0420 |